1. Verapamil delivery systems on the basis of mesoporous ZSM-5/KIT-6 and ZSM-5/SBA-15 polymer nanocomposites as a potential tool to overcome MDR in cancer cells.
- Author
-
Popova M, Mihaylova R, Momekov G, Momekova D, Lazarova H, Trendafilova I, Mitova V, Koseva N, Mihályi J, Shestakova P, St Petkov P, Aleksandrov HA, Vayssilov GN, Konstantinov S, and Szegedi Á
- Subjects
- Cell Line, Tumor, Chitosan chemistry, Doxorubicin chemistry, Drug Carriers chemistry, Drug Compounding methods, Drug Delivery Systems methods, HL-60 Cells, HT29 Cells, Humans, Hydrogen-Ion Concentration, Nanoparticles chemistry, Porosity, Antineoplastic Agents chemistry, Drug Resistance, Multiple drug effects, Nanocomposites chemistry, Polymers chemistry, Silicon Dioxide chemistry, Verapamil chemistry
- Abstract
ZSM-5/KIT-6 and ZSM-5/SBA-15 nanoparticles were synthesized and further modified by a post-synthesis method with (CH
2 )3 SO3 H and (CH2 )3 NHCO(CH2 )2 COOH groups to optimize their drug loading and release kinetic profiles. The verapamil cargo drug was loaded by incipient wetness impregnation both on the parent and modified nanoporous supports. Nanocarriers were then coated with a three-layer polymeric shell composed of chitosan-k-carrageenan-chitosan with grafted polysulfobetaine chains. The parent and drug loaded formulations were characterized by powder XRD, N2 physisorption, thermal analysis, AFM, DLS, TEM, ATR-FT-IR and solid state NMR spectroscopies. Loading of verapamil on such nanoporous carriers and their subsequent polymer coating resulted in a prolonged in vitro release of the drug molecules. Quantum-chemical calculations were performed to investigate the strength of the interaction between the specific functional groups of the drug molecule and (CH2 )3 SO3 H and CH2 )3 NHCO(CH2 )2 COOH groups of the drug carrier. Furthermore, the ability of the developed nanocomposites to positively modulate the intracellular internalization and thereby augment the antitumor activity of the p-gp substrate drug doxorubicin was investigated in a comparative manner vs. free drug in a panel of MDR positive (HL-60/Dox, HT-29) and MDR negative (HL-60) human cancer cell lines using the Chou-Talalay method., (Copyright © 2019 Elsevier B.V. All rights reserved.)- Published
- 2019
- Full Text
- View/download PDF